Today's Globe: new stem cell approach, kidney stones in kids, too much salt, generic biotech drugs
US researchers said yesterday that they have found a safer way to coax human skin cells into becoming embryonic-like stem cells, taking a step closer to their potential use as treatments for diseases.
Doctors are puzzling over what seems to be an increase in the number of children with kidney stones, a condition some blame on children's love of cheeseburgers, fries, and other salty foods.
People in the United States consume more than twice the recommended amount of salt, raising their risk for high blood pressure, heart attacks, and strokes, government health experts said yesterday.
Biotech drugs that now cost thousands of dollars per month would have to compete with lower-cost generic versions after just five years on the market, under a new congressional proposal.
This blogger might want to review your comment before posting it.
Contributors
blogger
Elizabeth Cooney is a former
health reporter for the Worcester Telegram & Gazette, where she also was a
business reporter and an editor. Earlier in her career, she edited medical
books and journals at Little, Brown, and worked for Boston magazine.Boston Globe Health and Science staff:
- Gideon Gil, Health and Science Editor
- Ishani Ganguli, Short White Coat blogger






